17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics: Difference between revisions
Jose Loyola (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{17-beta-hydroxysteroid dehydrogenase deficiency}} | {{17-beta-hydroxysteroid dehydrogenase deficiency}} | ||
== Epidemiology and Demographics == | ==Overview== | ||
In the Netherlands, [[17-beta-hydroxysteroid dehydrogenase deficiency]] is estimated to occur 1:147.000 newborns. It is more common in Gaza populations where it affects 1 in 200 to 300 people.<ref>{{cite journal |author=Boehmer A et al |title=17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations |journal=J Clin Endocrinol Metab |volume=84 |issue=12 |pages=4713-21 |year=1999 |pmid=10599740}}</ref> | ==Epidemiology and Demographics== | ||
*In the Netherlands, [[17-beta-hydroxysteroid dehydrogenase deficiency]] is estimated to occur 1:147.000 newborns. | |||
*It is more common in Gaza populations where it affects 1 in 200 to 300 people.<ref>{{cite journal |author=Boehmer A et al |title=17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations |journal=J Clin Endocrinol Metab |volume=84 |issue=12 |pages=4713-21 |year=1999 |pmid=10599740}}</ref> | |||
==References== | ==References== | ||
Revision as of 18:23, 9 May 2022
|
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics |
|
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics |
|
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics |
|
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics in the news |
|
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics |
|
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Overview
Epidemiology and Demographics
- In the Netherlands, 17-beta-hydroxysteroid dehydrogenase deficiency is estimated to occur 1:147.000 newborns.
- It is more common in Gaza populations where it affects 1 in 200 to 300 people.[1]